Faced with intense competition and rising valuation multiples to acquire high-quality healthcare platforms, healthcare private equity firms need to enhance their diligence efforts and expand their value creation playbooks to mitigate risk and continue to yield outsized returns relative to other sectors and public markets, MedCity News reports.
During the pandemic, there’s been a convergence of several secular and short-term trends that have fueled steady growth in healthcare PE. The tremendous amount of dry powder awaiting deployment and the cheap and accessible financing have played a key part in driving deal volume and rising valuation multiples across most sectors of healthcare services. Read more.
